Esperion Therapeutics and Oberland Capital Management LLC Revenue-Based Funding Agreement - Conference Call Transcript
Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Oberland Capital-Esperion Revenue-Based Funding Agreement Call. (Operator Instructions)
Now it's my pleasure to turn the call to Alex Schwartz, Head of Investor Relations.
Thank you, Carmen. Good afternoon, everyone, and thank you, for joining us. With me today from Esperion are Tim Mayleben, President and Chief Executive Officer; Rick Bartram, Chief Financial Officer; and Mark Glickman, Chief Commercial Officer.
I'd like to remind callers that the information discussed on the call today is covered under the safe harbor provisions of the Private Securities Litigation Reform Act. I caution listeners that management will be making forward-looking statements. Actual results could differ materially from those stated or implied by our forward-looking statements due to risk and uncertainties associated with the business.
These forward-looking statements are qualified in their entirety
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |